Real-time enrollment status for this dystrophic epidermolysis bullosa clinical trial
Current Status
Recruiting
Checked: July 22, 2026 at 12:09 AM UTC
| NCT Number | NCT04917887 |
| Recruiting Status | Recruiting |
| Condition | Dystrophic Epidermolysis Bullosa |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Krystal Biotech, Inc. |
| Last Updated on CT.gov | June 8, 2021 (Jun 8, 2021) |
As of July 22, 2026: Clinical trial NCT04917887 is currently recruiting participants. This clinical trial study for dystrophic epidermolysis bullosa is actively seeking new participants at 3 locations across the United States. The study is sponsored by Krystal Biotech, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04917887 is actively recruiting participants as of July 22, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04917887 was last updated Jun 8, 2021 (June 8, 2021). HelloStudys verifies this status automatically.